news_6

Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome

news_6

2020 Insights on the Impact of COVID-19 on the Asia-Pacific Energy and Environment Industry – New Opportunities as a Result of Economic Disruption – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disruptive Global Pandemic Calls for Business Innovations in the Asia-Pacific Energy and Environment Industry, 2020" report has been...